Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Elective neck dissection in oral squamous cell carcinoma: Past, present and future.

de Bree R, Takes RP, Shah JP, Hamoir M, Kowalski LP, Robbins KT, Rodrigo JP, Sanabria A, Medina JE, Rinaldo A, Shaha AR, Silver C, Suárez C, Bernal-Sprekelsen M, Ferlito A.

Oral Oncol. 2019 Mar;90:87-93. doi: 10.1016/j.oraloncology.2019.01.016. Epub 2019 Feb 10. Review.

2.

Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG.

Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.

PMID:
30846169
3.

Depth of invasion alone as an indication for postoperative radiotherapy in small oral squamous cell carcinomas: An International Collaborative Study.

Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Köhler HF, Kreppel M, Cernea CR, Brandao J, Bachar G, Villaret AB, Fliss DM, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR; International Consortium for Outcome Research (ICOR) in Head and Neck Cancer.

Head Neck. 2019 Feb 24. doi: 10.1002/hed.25633. [Epub ahead of print]

PMID:
30801885
4.

Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.

Ibrahimpasic T, Ghossein R, Shah JP, Ganly I.

Thyroid. 2019 Mar;29(3):311-321. doi: 10.1089/thy.2018.0509.

PMID:
30747050
5.

Classification of GLOSSECTOMIES: Proposal for tongue cancer resections.

Ansarin M, Bruschini R, Navach V, Giugliano G, Calabrese L, Chiesa F, Medina JE, Kowalski LP, Shah JP.

Head Neck. 2019 Mar;41(3):821-827. doi: 10.1002/hed.25466. Epub 2019 Jan 2.

PMID:
30600861
6.

A systematic review of validated tools assessing functional and aesthetic outcomes following fibula free flap reconstruction of the mandible.

Petrovic I, Panchal H, De Souza Franca PD, Hernandez M, McCarthy CC, Shah JP.

Head Neck. 2019 Jan;41(1):248-255. doi: 10.1002/hed.25452. Epub 2018 Dec 12. Review.

PMID:
30548509
7.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
8.

Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer.

Shaha AR, Migliacci JC, Nixon IJ, Wang LY, Wong RJ, Morris LGT, Patel SG, Shah JP, Tuttle RM, Ganly I.

Surgery. 2019 Jan;165(1):6-11. doi: 10.1016/j.surg.2018.04.078. Epub 2018 Nov 8.

PMID:
30415873
9.

Endosseous (dental) implants in an oncologic population: a primer for treatment considerations.

Petrovic I, Ahmed ZU, Matros E, Huryn JM, Shah JP, Rosen EB.

Quintessence Int. 2018 Nov 8:2-10. doi: 10.3290/j.qi.a41336. [Epub ahead of print]

PMID:
30411093
10.

Summary of the Third World Congress on Thyroid Cancer.

McIver B, Freeman J, Shah JP, Shaha AR, Haugen B, Cohen E, Witterick IJ, Randolph GW.

Thyroid. 2018 Nov;28(11):1401-1405. doi: 10.1089/thy.2018.0616. No abstract available.

PMID:
30303467
11.

The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study.

Fridman E, Na'ara S, Agarwal J, Amit M, Bachar G, Villaret AB, Brandao J, Cernea CR, Chaturvedi P, Clark J, Ebrahimi A, Fliss DM, Jonnalagadda S, Kohler HF, Kowalski LP, Kreppel M, Liao CT, Patel SG, Patel RS, Robbins KT, Shah JP, Shpitzer T, Yen TC, Zöller JE, Gil Z; International Consortium for Outcome Research in Head and Neck Cancer.

Cancer. 2018 Jul 15;124(14):2948-2955. doi: 10.1002/cncr.31531. Epub 2018 May 14.

PMID:
29757457
12.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
13.

Oral rehabilitation of the cancer patient: A formidable challenge.

Petrovic I, Rosen EB, Matros E, Huryn JM, Shah JP.

J Surg Oncol. 2018 Jun;117(8):1729-1735. doi: 10.1002/jso.25075. Epub 2018 May 3. Review.

PMID:
29723421
14.

Staging for Head and Neck Cancer: Purpose, Process and Progress.

Shah JP.

Indian J Surg Oncol. 2018 Mar;9(1):116-120. doi: 10.1007/s13193-018-0723-0. Epub 2018 Feb 5.

15.

Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.

Mizrachi A, Migliacci JC, Montero PH, McBride S, Shah JP, Patel SG, Ganly I.

Oral Oncol. 2018 Mar;78:94-101. doi: 10.1016/j.oraloncology.2018.01.020. Epub 2018 Feb 20.

16.

Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers?

Gupta P, Migliacci JC, Montero PH, Zanoni DK, Shah JP, Patel SG, Ganly I.

Oral Oncol. 2018 Mar;78:64-71. doi: 10.1016/j.oraloncology.2018.01.013. Epub 2018 Feb 20.

17.

Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review.

Rodrigo JP, Grilli G, Shah JP, Medina JE, Robbins KT, Takes RP, Hamoir M, Kowalski LP, Suárez C, López F, Quer M, Boedeker CC, de Bree R, Coskun H, Rinaldo A, Silver CE, Ferlito A.

Eur J Surg Oncol. 2018 Apr;44(4):395-403. doi: 10.1016/j.ejso.2018.01.003. Epub 2018 Jan 11. Review.

PMID:
29395434
18.

Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A.

Head Neck. 2018 Apr;40(4):855-866. doi: 10.1002/hed.25029. Epub 2017 Dec 5. Review.

PMID:
29206325
19.

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, Untch B, Ganly I, Shaha AR, Shah JP, Pace M, Li D, Bach A, Lin O, Whiting A, Ghossein R, Landa I, Sabra M, Boucai L, Fish S, Morris LGT.

JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.

20.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
21.

Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database.

Roman BR, Baxi SS, Cracchiolo JR, Blackwell TJ, Pfister DG, McBride S, Ganly I, Shah JP, Patel SG, Morris LG, Cohen MA.

J Surg Oncol. 2017 Sep;116(3):351-358. doi: 10.1002/jso.24674. Epub 2017 Jun 1.

22.

Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancer.

Wang LY, Migliacci JC, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Clin Endocrinol (Oxf). 2017 Nov;87(5):566-571. doi: 10.1111/cen.13378. Epub 2017 Jun 14.

23.

Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation.

Ali S, Palmer FL, Katabi N, Lee N, Shah JP, Patel SG, Ganly I.

Laryngoscope. 2017 Oct;127(10):2265-2269. doi: 10.1002/lary.26565. Epub 2017 Mar 21.

24.

A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue.

Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, Shah JP, Wong RJ, Ghossein RA, Patel SG.

JAMA Otolaryngol Head Neck Surg. 2017 Jun 1;143(6):555-560. doi: 10.1001/jamaoto.2016.4238.

25.

Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP.

CA Cancer J Clin. 2017 Mar;67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27.

26.

Patient Reflections on Decision Making for Laryngeal Cancer Treatment.

Shuman AG, Larkin K, Thomas D, Palmer FL, Fins JJ, Baxi SS, Lee N, Shah JP, Fagerlin A, Patel SG.

Otolaryngol Head Neck Surg. 2017 Feb;156(2):299-304. doi: 10.1177/0194599816683377. Epub 2017 Jan 24.

27.

Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity.

Petrovic I, Montero PH, Migliacci JC, Palmer FL, Ganly I, Patel SG, Shah JP.

J Craniomaxillofac Surg. 2017 Feb;45(2):252-257. doi: 10.1016/j.jcms.2016.11.017. Epub 2016 Nov 30.

28.

Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.

Shaha MA, Wang LY, Migliacci JC, Palmer FL, Nixon IJ, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Thyroid. 2017 Mar;27(3):412-417. doi: 10.1089/thy.2016.0303. Epub 2017 Feb 16.

29.

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.

Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, Xiao YP, Kan WK, O'Sullivan B, Xu W, Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shah JP, Lee AW.

Cancer. 2016 Nov 15;122(21):3307-3315. doi: 10.1002/cncr.30198. Epub 2016 Jul 19.

30.

Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.

Ho AS, Zumsteg ZS, Meyer A, Riaz N, Rahmati R, Kraus DH, McCarthy C, Wong RJ, Shah JP, Lee NY.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):850-857. Epub 2016 Aug 9.

31.

Management of Invasive Differentiated Thyroid Cancer.

Nixon IJ, Simo R, Newbold K, Rinaldo A, Suarez C, Kowalski LP, Silver C, Shah JP, Ferlito A.

Thyroid. 2016 Sep;26(9):1156-66. doi: 10.1089/thy.2016.0064. Epub 2016 Aug 23. Review.

32.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LG, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2016 Jul 21. doi: 10.1001/jamaoncol.2016.1790. [Epub ahead of print]

33.

Operative management of locally advanced, differentiated thyroid cancer.

Wang LY, Nixon IJ, Patel SG, Palmer FL, Tuttle RM, Shaha A, Shah JP, Ganly I.

Surgery. 2016 Sep;160(3):738-46. doi: 10.1016/j.surg.2016.04.027. Epub 2016 Jun 11.

34.

Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.

Dogan S, Wang L, Ptashkin RN, Dawson RR, Shah JP, Sherman EJ, Michael Tuttle R, Fagin JA, Klimstra DS, Katabi N, Ghossein RA.

Mod Pathol. 2016 Sep;29(9):985-95. doi: 10.1038/modpathol.2016.115. Epub 2016 Jun 10.

35.

Treatment of large tracheal defects after resection: Laryngotracheal release and tracheal replacement.

Kirschbaum A, Teymoortash A, Suárez C, Shah JP, Silver CE, Nixon I, Rinaldo A, Kowalski LP, Robbins KT, Ferlito A.

Auris Nasus Larynx. 2016 Dec;43(6):602-8. doi: 10.1016/j.anl.2016.03.009. Epub 2016 Apr 14. Review.

36.

Cervical Lymph Node Metastasis in Adenoid Cystic Carcinoma of the Larynx: A Collective International Review.

Coca-Pelaz A, Barnes L, Rinaldo A, Cardesa A, Shah JP, Rodrigo JP, Suárez C, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Wenig BM, Strojan P, Hamoir M, Bradley PJ, Gnepp DR, Silver CE, Slootweg PJ, Triantafyllou A, Vander Poorten V, Williams MD, Skálová A, Hellquist H, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Takes RP, Ferlito A.

Adv Ther. 2016 Apr;33(4):553-79. doi: 10.1007/s12325-016-0311-z. Epub 2016 Mar 19. Review.

37.

Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.

Suárez C, Barnes L, Silver CE, Rodrigo JP, Shah JP, Triantafyllou A, Rinaldo A, Cardesa A, Pitman KT, Kowalski LP, Robbins KT, Hellquist H, Medina JE, de Bree R, Takes RP, Coca-Pelaz A, Bradley PJ, Gnepp DR, Teymoortash A, Strojan P, Mendenhall WM, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Hamoir M, Slootweg PJ, Vander Poorten V, Williams MD, Wenig BM, Skálová A, Ferlito A.

Auris Nasus Larynx. 2016 Oct;43(5):477-84. doi: 10.1016/j.anl.2016.02.013. Epub 2016 Mar 24. Review.

38.

Pattern of neck recurrence after lateral neck dissection for cervical metastases in papillary thyroid cancer.

McNamara WF, Wang LY, Palmer FL, Nixon IJ, Shah JP, Patel SG, Ganly I.

Surgery. 2016 Jun;159(6):1565-1571. doi: 10.1016/j.surg.2016.02.005. Epub 2016 Mar 16.

39.

An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP.

Thyroid. 2016 Mar;26(3):373-80. doi: 10.1089/thy.2015.0315. Epub 2016 Feb 25.

40.

Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review.

Hellquist H, Skálová A, Barnes L, Cardesa A, Thompson LD, Triantafyllou A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suárez C, Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes RP, Rinaldo A, Ferlito A.

Adv Ther. 2016 Mar;33(3):357-68. doi: 10.1007/s12325-016-0298-5. Epub 2016 Feb 19. Review.

41.

Patterns of regional and distant metastasis in esthesioneuroblastoma.

Banuchi VE, Dooley L, Lee NY, Pfister DG, McBride S, Riaz N, Bilsky MH, Ganly I, Shah JP, Kraus DH, Morris LG.

Laryngoscope. 2016 Jul;126(7):1556-61. doi: 10.1002/lary.25862. Epub 2016 Feb 10.

42.

Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.

Wang LY, Roman BR, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Surgery. 2016 May;159(5):1390-5. doi: 10.1016/j.surg.2015.11.018. Epub 2015 Dec 31.

43.

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.

Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ, Sze HC, Chen YB, Choi HC, Guo QJ, Kan WK, Xiao YP, Wei X, Le QT, Glastonbury CM, Colevas AD, Weber RS, Shah JP, Lee AW.

Cancer. 2016 Feb 15;122(4):546-58. doi: 10.1002/cncr.29795. Epub 2015 Nov 20.

44.

Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

Head Neck. 2016 Apr;38 Suppl 1:E1192-9. doi: 10.1002/hed.24190. Epub 2015 Oct 30.

45.

Individualized Risk Estimation for Postoperative Complications After Surgery for Oral Cavity Cancer.

Awad MI, Palmer FL, Kou L, Yu C, Montero PH, Shuman AG, Ganly I, Shah JP, Kattan MW, Patel SG.

JAMA Otolaryngol Head Neck Surg. 2015 Nov;141(11):960-8. doi: 10.1001/jamaoto.2015.2200.

46.

Incidental findings of thyroid tissue in cervical lymph nodes: old controversy not yet resolved?

Triantafyllou A, Williams MD, Angelos P, Shah JP, Westra WH, Hunt JL, Devaney KO, Rinaldo A, Slootweg PJ, Gnepp DR, Silver C, Ferlito A.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2867-75. doi: 10.1007/s00405-015-3786-3. Epub 2015 Oct 12. Review.

47.

Thyroid carcinoma: epidemiology, histology, and diagnosis.

Shah JP.

Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-6. No abstract available.

48.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

49.

Cost-effectiveness analysis of papillary thyroid cancer surveillance.

Wang LY, Roman BR, Migliacci JC, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I.

Cancer. 2015 Dec 1;121(23):4132-40. doi: 10.1002/cncr.29633. Epub 2015 Aug 17.

50.

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP.

Ann Surg Oncol. 2016 Feb;23(2):410-5. doi: 10.1245/s10434-015-4762-2. Epub 2015 Jul 28.

Supplemental Content

Loading ...
Support Center